Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 45 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

27%

12 trials in Phase 3/4

Results Transparency

6%

1 of 18 completed trials have results

Key Signals

2 recruiting1 with results

Enrollment Performance

Analytics

N/A
13(36.1%)
Phase 4
12(33.3%)
Phase 1
6(16.7%)
Phase 2
5(13.9%)
36Total
N/A(13)
Phase 4(12)
Phase 1(6)
Phase 2(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (45)

Showing 20 of 45 trials
NCT07563335Not ApplicableEnrolling By Invitation

Stage-Matched Psychosocial Intervention for Parent Caregivers of Children With Leukemia in Pakistan

Role: lead

NCT05029141Phase 2Active Not Recruiting

New Double Epigenetic Regimen in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia

Role: collaborator

NCT04869592Phase 1Completed

A Clinical Trial to Evaluate the Recombinant SARS-CoV-2 Vaccine (CHO Cell) for COVID-19

Role: collaborator

NCT07319481Not ApplicableNot Yet Recruiting

Preliminary Effectiveness and Feasibility of Transcutaneous Acupoints Electrical Stimulation on Chemotherapy-induced Peripheral Neuropathy Among Children With Acute Lymphoblastic Leukemia

Role: collaborator

NCT07306390Not Yet Recruiting

Distribution and Analysis of Metastatic Lymph Nodes in Colorectal Cancer Patients (DIAMOND)

Role: collaborator

NCT07299331Not ApplicableNot Yet Recruiting

Zanubrutinib, Rituximab, and Lenalidomide in the First-Line Treatment of Marginal Zone Lymphoma

Role: lead

NCT07264894Phase 4Not Yet Recruiting

ZSDT for the Treatment of R/R Mantle Cell Lymphoma After BTK Inhibitor Failure: a Multi-center Prospective Clinical Trial

Role: lead

NCT07198464Not ApplicableNot Yet Recruiting

Relmacabtagene Autoleucel Combined With Autologous Hematopoietic Stem Cell Transplantation, Orelabrutinib, and Sintilimab for Primary Central Nervous System Lymphoma

Role: lead

NCT07185308Not ApplicableNot Yet Recruiting

Postbiotics Ameliorate Cachexia in Patients With Non-small-cell Lung Cancer

Role: collaborator

NCT07117305Phase 1Not Yet Recruiting

CD7 CAR-T Combined With Autologous Hematopoietic Stem Cell Transplantation

Role: lead

NCT06783933Active Not Recruiting

Artificial Intelligence-assisted Diagnosis

Role: collaborator

NCT07046182Phase 4Active Not Recruiting

Clinical Study of CEP+Dasatinib + Azacytidine in First-line Treatment of. Angioimmunoblastoma Foresight

Role: lead

NCT06742879Active Not Recruiting

A Multi-center Clinical Study of Zanubrutinib in Combination With First-line Chemoimmunotherapy in Patients With Grade 3A High-risk Follicular Lymphoma

Role: lead

NCT06956092Phase 4Not Yet Recruiting

Glofitamab for Consolidation After First-line Treatment of High-risk Large B-cell Lymphoma

Role: lead

NCT06827093Not ApplicableCompleted

Dyadic Interventions to Boost Quality of Life Among Stroke Survivors and Care Partners in Pakistan.

Role: lead

NCT05781243Phase 4Completed

Normal Saline Versus Lactated Ringer's Solution for Acute Pancreatitis Resuscitation

Role: collaborator

NCT06609304Phase 4Recruiting

Axicabtagene Ciloleucel for Consolidation After First-line Treatment of High-risk Large B-cell Lymphoma

Role: lead

NCT06245850Not ApplicableCompleted

Impact of Baduanjin Exercise Combined With Rational Emotive Behavior Therapy on Sleep and Mood in Patients With Post-stroke Depression

Role: lead

NCT06172608Not ApplicableUnknown

Effect of Educational Program on Parental Stress of Parents of Children With CHD

Role: lead

NCT05918289Not ApplicableCompleted

Improving Wellbeing in Older Adults: The Impact of an Active Aging Education Program in Pakistan

Role: lead